A phase 2 study of the BH3 mimetic BCL2 inhibitor navitoclax (ABT-263) with or without rituximab, in previously untreated B-cell chronic lymphocytic leukemia

Leukemia and Lymphoma - Tập 56 Số 10 - Trang 2826-2833 - 2015
Thomas J. Kipps1, Herbert Eradat2, Sebastian Grosicki3, John Catalano4, W Cosolo5, Iryna Dyagil6, Sreeni Yalamanchili7, Akiko Chai7, Srikumar Sahasranaman7, Elizabeth A. Punnoose7, Deborah Hurst7, Halyna Pylypenko8
1Department of Hematology-Oncology, UCSD School of Medicine, San Diego, CA, USA
2Division of Hematology-Oncology, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA
3Department of Hematology, Community Hospitals, Chorzow, Poland
4Frankston Hospital and Monash University, Frankston, Australia
5John Fawkner Cancer Trial Centre, Coburg, Australia
6Department of Hematology, National Research Center for Radiation Medicine of National Medical Academy of Sciences of Ukraine, Kyiv, Ukraine
7Genentech Inc., South San Francisco, CA, USA.
8Department of Hematology, Cherkassy Regional Oncological Center, Cherkassy, Ukraine

Tóm tắt

Từ khóa


Tài liệu tham khảo

Barille-Nion S, 2012, Anticancer Res, 32, 4225

10.1007/978-1-4614-8051-8_7

10.1158/1535-7163.MCT-13-0058

10.1038/nature03579

10.1172/JCI28281

10.1158/0008-5472.CAN-07-5836

Tedeschi A, 2010, Oncol Targets Ther, 3, 227

10.1007/s00280-009-1232-1

10.1111/j.1476-5381.2012.02048.x

10.1182/blood-2011-03-340364

10.1182/blood-2011-12-400929

10.1200/JCO.2011.34.7898

10.1182/blood-2007-06-093906

10.1097/00000421-198212000-00014

10.1111/bjh.12757

10.1002/1097-0142(19810701)48:1<198::AID-CNCR2820480131>3.0.CO;2-V

10.1182/blood-2005-04-1677

10.1111/bjh.12534

10.1016/S0140-6736(10)61381-5

10.1016/S1470-2045(10)70261-8

10.1124/dmd.113.055053

10.1097/00007691-200006000-00010

10.1309/820R476KY9G03L9A

10.1016/j.otohns.2010.05.007

10.1038/nm.3048

10.1177/0091270011430506

10.1053/j.gastro.2010.02.054

10.1182/blood-2011-04-347849

Thông tin
Thông tin xuất bản

Leukemia and Lymphoma

Tập 56 Số 10

2826-2833

Thông tin tác giả